SYNERON MEDICAL LTD's ticker is ELOS and the CUSIP is M87245102. A total of 67 filers reported holding SYNERON MEDICAL LTD in Q4 2013. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2017 | $23,234,000 | -26.8% | 2,202,272 | -41.7% | 1.66% | -26.4% |
Q4 2016 | $31,733,000 | +15.3% | 3,777,775 | -1.7% | 2.26% | +14.7% |
Q3 2016 | $27,518,000 | -6.9% | 3,843,251 | 0.0% | 1.97% | -18.5% |
Q2 2016 | $29,555,000 | +4.4% | 3,843,251 | -0.8% | 2.42% | +1.7% |
Q1 2016 | $28,322,000 | -5.4% | 3,874,351 | -0.3% | 2.38% | +5.8% |
Q4 2015 | $29,948,000 | +7.8% | 3,884,351 | 0.0% | 2.25% | +12.4% |
Q3 2015 | $27,773,000 | -29.1% | 3,884,351 | +5.3% | 2.00% | -18.2% |
Q2 2015 | $39,168,000 | -14.2% | 3,688,151 | 0.0% | 2.45% | -13.5% |
Q1 2015 | $45,659,000 | +32.7% | 3,688,151 | 0.0% | 2.83% | +15.2% |
Q4 2014 | $34,410,000 | -6.8% | 3,688,151 | +0.1% | 2.45% | -29.0% |
Q3 2014 | $36,915,000 | -2.9% | 3,684,151 | 0.0% | 3.46% | +4.1% |
Q2 2014 | $38,020,000 | -15.9% | 3,684,151 | +1.4% | 3.32% | -5.6% |
Q1 2014 | $45,225,000 | +75.6% | 3,632,536 | +21.6% | 3.52% | +22.8% |
Q3 2013 | $25,759,000 | +1.0% | 2,988,261 | +1.9% | 2.86% | -13.1% |
Q2 2013 | $25,512,000 | – | 2,932,384 | – | 3.30% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|